<html>
<head>PUBMED IDs for MTf</head>
<body bgcolor='#C5F0F2'><h1>MTf</h1><a href='https://pubmed.ncbi.nlm.nih.gov/3135940/'>The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes.</a> August 12  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/1614870/'>Identification of an enhancer involved in the melanoma-specific expression of the tumor antigen melanotransferrin gene.</a> June 11  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/8836133/'>Melanotransferrin gene expression in melanoma cells is correlated with high levels of Jun/Fos family transcripts and with the presence of a specific AP1-dependent ternary complex.</a> September 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/10529437/'>Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease.</a> October 26  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11852110/'>A second melanotransferrin gene (MTf2) and a novel protein isoform: explanation for the membrane-bound and soluble forms of melanotransferrin?</a> February 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/16704991/'>The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.</a> May 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17167498/'>Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model.</a> December 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17449903/'>Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.</a> April 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17452986/'>The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.</a> April 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19245822/'>Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotype.</a> August 19  2009<br></body></html>
